THU0124 Importance of monitoring of C-reactive protein level to predict achievement of better clinical outcome during treatment with tocilizumab in patients with rheumatoid arthritis

Abstract

BackgroundBiologics have molecular target such as cytokine and its receptor. It should be critical for maximizing its clinical response how biologics completely inhibit signalling of the target cytokines. However, it...